ClinicalTrials.gov record
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
ClinicalTrials.gov ID: NCT01846520
Public ClinicalTrials.gov record NCT01846520. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
ClinicalTrials.gov public records Last synced May 20, 2026, 12:43 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Trial of a Family Caregiver Palliative Care Intervention
Study identification
- NCT ID
- NCT01846520
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- City of Hope Medical Center
- Other
- Enrollment
- 200 participants
Conditions and interventions
Conditions
- Healthy Subject
- Localized Transitional Cell Cancer of the Renal Pelvis and Ureter
- Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
- Psychosocial Effects of Cancer and Its Treatment
- Recurrent Bladder Cancer
- Recurrent Cervical Cancer
- Recurrent Colon Cancer
- Recurrent Gastric Cancer
- Recurrent Ovarian Epithelial Cancer
- Recurrent Ovarian Germ Cell Tumor
- Recurrent Pancreatic Cancer
- Recurrent Rectal Cancer
- Recurrent Renal Cell Cancer
- Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
- Recurrent Urethral Cancer
- Recurrent Uterine Sarcoma
- Regional Transitional Cell Cancer of the Renal Pelvis and Ureter
- Stage II Bladder Cancer
- Stage II Renal Cell Cancer
- Stage II Urethral Cancer
- Stage IIA Cervical Cancer
- Stage IIA Colon Cancer
- Stage IIA Gastric Cancer
- Stage IIA Lung Carcinoma
- Stage IIA Ovarian Epithelial Cancer
- Stage IIA Ovarian Germ Cell Tumor
- Stage IIA Pancreatic Cancer
- Stage IIA Rectal Cancer
- Stage IIA Uterine Sarcoma
- Stage IIB Cervical Cancer
- Stage IIB Colon Cancer
- Stage IIB Gastric Cancer
- Stage IIB Lung Carcinoma
- Stage IIB Ovarian Epithelial Cancer
- Stage IIB Ovarian Germ Cell Tumor
- Stage IIB Pancreatic Cancer
- Stage IIB Rectal Cancer
- Stage IIB Uterine Sarcoma
- Stage IIC Colon Cancer
- Stage IIC Ovarian Epithelial Cancer
- Stage IIC Ovarian Germ Cell Tumor
- Stage IIC Rectal Cancer
- Stage III Bladder Cancer
- Stage III Pancreatic Cancer
- Stage III Renal Cell Cancer
- Stage III Urethral Cancer
- Stage IIIA Cervical Cancer
- Stage IIIA Colon Cancer
- Stage IIIA Gastric Cancer
- Stage IIIA Lung Carcinoma
- Stage IIIA Ovarian Epithelial Cancer
- Stage IIIA Ovarian Germ Cell Tumor
- Stage IIIA Rectal Cancer
- Stage IIIA Uterine Sarcoma
- Stage IIIB Cervical Cancer
- Stage IIIB Colon Cancer
- Stage IIIB Gastric Cancer
- Stage IIIB Lung Carcinoma
- Stage IIIB Ovarian Epithelial Cancer
- Stage IIIB Ovarian Germ Cell Tumor
- Stage IIIB Rectal Cancer
- Stage IIIB Uterine Sarcoma
- Stage IIIC Colon Cancer
- Stage IIIC Gastric Cancer
- Stage IIIC Ovarian Epithelial Cancer
- Stage IIIC Ovarian Germ Cell Tumor
- Stage IIIC Rectal Cancer
- Stage IIIC Uterine Sarcoma
- Stage IV Bladder Cancer
- Stage IV Gastric Cancer
- Stage IV Ovarian Epithelial Cancer
- Stage IV Ovarian Germ Cell Tumor
- Stage IV Pancreatic Cancer
- Stage IV Renal Cell Cancer
- Stage IV Urethral Cancer
- Stage IVA Cervical Cancer
- Stage IVA Colon Cancer
- Stage IVA Rectal Cancer
- Stage IVA Uterine Sarcoma
- Stage IVB Cervical Cancer
- Stage IVB Colon Cancer
- Stage IVB Rectal Cancer
- Stage IVB Uterine Sarcoma
- Ureter Cancer
Interventions
- educational intervention Other
- quality-of-life assessment Procedure
- questionnaire administration Other
- telephone-based intervention Behavioral
Other · Procedure · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2013
- Primary completion
- May 22, 2019
- Completion
- May 22, 2019
- Last update posted
- Jan 22, 2020
2013 – 2019
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope Medical Center | Duarte | California | 91010 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01846520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 22, 2020 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01846520 live on ClinicalTrials.gov.